Amgen (AMGN) Net Cash Flow Growth (1y) (2010 - 2026)
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Novartis Ag |
107,124,802.25 Bn |
107,124,802.25 Bn |
- |
- |
| 2 |
Eli Lilly |
969.00 Bn |
963.72 Bn |
16.22 Bn |
-568.73% |
| 3 |
Johnson & Johnson |
539.46 Bn |
517.41 Bn |
15.96 Bn |
-85.99% |
| 4 |
AbbVie |
376.92 Bn |
367.57 Bn |
10.78 Bn |
1,265.92% |
| 5 |
Merck |
285.00 Bn |
279.35 Bn |
12.09 Bn |
-95.55% |
| 6 |
Amgen |
177.58 Bn |
165.55 Bn |
5.87 Bn |
191.97% |
| 7 |
Gilead Sciences |
163.22 Bn |
155.50 Bn |
5.52 Bn |
103.60% |
| 8 |
Pfizer |
145.86 Bn |
133.09 Bn |
-1.21 Bn |
42.41% |
| 9 |
Bristol Myers Squibb |
111.90 Bn |
101.44 Bn |
8.07 Bn |
-227.06% |
| 10 |
Gsk |
88.34 Bn |
83.66 Bn |
- |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
191.97% |
| Dec 31, 2025 |
-110.67% |
| Sep 30, 2025 |
588.62% |
| Jun 30, 2025 |
-92.14% |
| Mar 31, 2025 |
-155.91% |
| Dec 31, 2024 |
112.45% |
| Sep 30, 2024 |
-158.82% |
| Jun 30, 2024 |
-115.14% |
| Mar 31, 2024 |
-105.16% |
| Dec 31, 2023 |
-1,170.53% |
| Sep 30, 2023 |
-88.53% |
| Jun 30, 2023 |
302.87% |
| Mar 31, 2023 |
1,737.99% |
| Dec 31, 2022 |
52.94% |
| Sep 30, 2022 |
-19.48% |
| Jun 30, 2022 |
-355.79% |
| Mar 31, 2022 |
-848.70% |
| Dec 31, 2021 |
-41.08% |
| Sep 30, 2021 |
9,305.17% |
| Jun 30, 2021 |
-64.47% |
| Mar 31, 2021 |
-109.33% |
| Dec 31, 2020 |
47.55% |
| Sep 30, 2020 |
-100.98% |
| Jun 30, 2020 |
179.54% |
| Mar 31, 2020 |
299.52% |
| Dec 31, 2019 |
-7.32% |
| Sep 30, 2019 |
222.74% |
| Jun 30, 2019 |
-570.00% |
| Mar 31, 2019 |
-93.05% |
| Dec 31, 2018 |
-726.38% |
| Sep 30, 2018 |
391.91% |
| Jun 30, 2018 |
153.50% |
| Mar 31, 2018 |
4,977.78% |
| Dec 31, 2017 |
427.87% |
| Sep 30, 2017 |
-56.61% |
| Jun 30, 2017 |
-174.06% |
| Mar 31, 2017 |
109.38% |
| Dec 31, 2016 |
-126.58% |
| Sep 30, 2016 |
250.26% |
| Jun 30, 2016 |
-128.57% |
| Mar 31, 2016 |
-43.94% |
| Dec 31, 2015 |
1,600.00% |
| Sep 30, 2015 |
15.70% |
| Jun 30, 2015 |
40.00% |
| Mar 31, 2015 |
-634.75% |
| Dec 31, 2014 |
101.21% |
| Sep 30, 2014 |
-127.27% |
| Jun 30, 2014 |
-79.70% |
| Mar 31, 2014 |
83.77% |
| Dec 31, 2013 |
-74.43% |
| Sep 30, 2013 |
9,619.23% |
| Jun 30, 2013 |
99.51% |
| Mar 31, 2013 |
73.46% |
| Dec 31, 2012 |
-183.99% |
| Sep 30, 2012 |
98.77% |
| Jun 30, 2012 |
-65.30% |
| Mar 31, 2012 |
-35.53% |
| Dec 31, 2011 |
809.23% |
| Sep 30, 2011 |
-270.06% |
| Jun 30, 2011 |
954.15% |
| Mar 31, 2011 |
-227.02% |
| Dec 31, 2010 |
148.48% |
| Sep 30, 2010 |
103.45% |
| Jun 30, 2010 |
-390.05% |
| Mar 31, 2010 |
-161.62% |
